Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database ; day:22 ; month:6 ; year:2024 ; pages:1-10
Drugs - real world outcomes ; (22.6.2024), 1-10
- Creator
-
Bahta, Merhawi
Russom, Natnael
Ghebrenegus, Amon Solomon
Okubamichael, Yohana Tecleab
Russom, Mulugeta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-024-00441-2
- URN
-
urn:nbn:de:101:1-2411121036210.000820913493
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bahta, Merhawi
- Russom, Natnael
- Ghebrenegus, Amon Solomon
- Okubamichael, Yohana Tecleab
- Russom, Mulugeta
- SpringerLink (Online service)
Other Objects (12)
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
PROGgeneV2: enhancements on the existing database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Big data, medicines safety and pharmacovigilance
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
PROGgeneV2: enhancements on the existing database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Big data, medicines safety and pharmacovigilance
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
PROGgeneV2: enhancements on the existing database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Big data, medicines safety and pharmacovigilance
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database